CMNDNasdaqPharmaceutical PreparationsFiscal year ends October 31
Clearmind Medicine Inc.
Financials through Q3 FY2026, quarter ended Jul 31, 2026
$6.00−0.26 (-4.15%)
Close on Oct 19, 2026
- Market cap
- $9.49M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$3,058.96 (−99.80%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jul 31, 2026
Valuation
- Market cap
- $9.49M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- EPS, diluted
- -$30.35
- Diluted shares
- 2M
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months